Skip to main content
Tech.euFundingExplorerBeta

Orphazyme

New therapies for the treatment of rare and genetic diseases

Copenhagen, DenmarkFounded 2009www.orphazyme.com ↗
Healthtech
← All companies
Total raised
€40M
€39,999,999
Funding rounds
3
Investors
4
distinct backers
Active since
2011-01
latest 2014-12

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood21
base rate 48% for Series B
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
Exit likelihood19
base rate 12% (2+ rounds)
  • ▲ 3 rounds raised
  • ▲ €30M+ raised
  • ▲ 17y since founding

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2015-01-01Series B€22MAescap,IDInvest Partners,Sunstone CapitalView deal →
2011-09-01Series A€18MAescap,Novo Ventures,Sunstone CapitalView deal →
2011-02-01Seed€0Novo Ventures,Sunstone CapitalView deal →

Investors

4
AescapIDInvest PartnersNovo VenturesSunstone Capital

Similar companies

same sector or country